Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > An exceptionally bright future on path to becoming ...
View:
Post by ScienceFirst on May 24, 2023 8:12pm

An exceptionally bright future on path to becoming ...

Theralase® has an exceptionally bright future and we look forward to having Roger lead us on the path to becoming a commercial-stage pharmaceutical company.

Apart from a news release from the FDA confirming the granting of a Brealthrough Theraphy desingation, it cannot get closer than that.

They sound like they are extremely confident.  This, right after the Dr. Kulkarni\Dr. Kamat interview, also sounds like their communications with the FDA has led them to conclude that we will succeed.
 
So I think it's fair to assume that it's a strong signal/milestone that Breakthrough Therapy application has now been submitted and that a positive response from the FDA leaves no doubt.  The FDA would now have 60 days to reply.
 
I also think that it's fair to assume that we might hear a bit more about their plans regarding Rutherrin (NSCLC, Glioblastoma) in a nearby future, most probably after the granting of the FDA Breakthrough Therapy designation, in order to gain maximum visibility.
Theralase® has an exceptionally bright future and we look forward to having Roger lead us on the path to becoming a commercial-stage pharmaceutical company.
Comment by Johnandrose22 on May 24, 2023 8:30pm
I agree, ScienceFirst...I believe this announcement was strategic and meaningful. Dr. Mandel...thank you. Mr. White...welcome back. Now lead this company to its full potential! John
Comment by Alamir1111 on May 24, 2023 9:20pm
John bible  stated  lead us to promise land Don't  see Mr White in z? 
Comment by Alamir1111 on May 24, 2023 9:50pm
Wish Mr ceo. Rdw the best of luck. Remember your actions will be remembered in history. Your vision is remarkable  so is your greed. You can help  lots a people praying for  one more day to see loved one..  But yore a human.  HIi your choicre
Comment by Eoganacht on May 25, 2023 11:32am
I agree that, in all likelihood, the timing was carefully planned. Roger was eligible to reassume the helm at the end of February, 3 months ago. It makes sense to wait until there is seriously good news to follow the announcement. The financials, along with an MD&A should be out next week and the AGM will be in 5 weeks. IMHO good news is on the way.
Comment by N0taP00p on May 25, 2023 11:34am
From your keyboard to God's ears
Comment by Oden6570 on May 25, 2023 11:40am
Show Me The Money !!!!!! At least upward sp movements that are sustained.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250